Immunomolecular mechanism of drug photosensitivity and screening for photoallergenicity of drugs
Immunomolecular mechanism of drug photosensitivity and screening for photoallergenicity of drugs
批准号:
14570804
负责人:
TOKURA Yoshiki
金额:
$2.56万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Photocontact dermatitis is one of the major occupational skin diseases and an undesirable adverse effect produced by chemicals and drugs in our environment. This dermatitis is caused by skin application of photosensitive agents plus ultraviolet light irradiation. There exist both primary irritant and allergic mechanisms in this dermatosis. While the former is induced by the phototoxic reactions, the latter allergic type is mediated by Langerhans cells, T lymphocytes, and various cytokines and chemokines, and thus occurs via a well-orchestrated and well-elucidated immunological mechanism. The photoallergic type has a higher incidence and more severe skin eruptions than the primary irritation. Photoconjugation of epidermal cells with a photohaptenic halogenated chemical is the initial step, and Langerhans cells serve as antigen-presenting cells. Causative photohaptens are bound to MHC class II molecules/self peptide on Langerhans cells upon exposure to UVA. The photomodified Langerhans cells sensitize and elicit antigen-specific T cells that mediate photoallergy. Thus, this photoallergy is induced by well-orchestrated photochemical and immunological mechanisms.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yagi S, Iwanaga T, Kojima H, Shoji Y, Suzuki S, Seo K, Mori H, Tokura Y, Takigawa M, Moriwaki S-I: "UV dose measurements of photosensitive dermatosis patients by polycrystalline GaN-based portable self-data-acquisition UV monitor."Photochem Photobiol. 76.
Yagi S、Iwanaga T、Kojima H、Shoji Y、Suzuki S、Seo K、Mori H、Tokura Y、Takikawa M、Moriwaki S-I:“通过基于多晶 GaN 的便携式自数据采集 UV 对光敏性皮肤病患者进行紫外线剂量测量
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tokura Y: "Immunological and molecular mechanisms of photoallergic contact dermatitis."Journal of UOEH. 25. 387-395 (2003)
Tokura Y:“光过敏性接触性皮炎的免疫学和分子机制。”UOEH 杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ito T, Seo N, Yagita H, Tsujimura K, Takigawa M, Tokura Y: "Alterations of immune functions in barrier disrupted skin by UVB irradiation"Journal of Dermatological Science. 33. 151-160 (2003)
Ito T、Seo N、Yagita H、Tsujimura K、Takikawa M、Tokura Y:“UVB 照射对屏障破坏皮肤中免疫功能的改变”皮肤病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Yamamoto O, Tokura Y: "Photocontact dermatitis and chloracne : two major occupational and environmental skin disease induced by different actions of halogenated chemicals"Journal of Dematological Science. 32. 85-94 (2003)
Yamamoto O,Tokura Y:“光接触性皮炎和氯痤疮:卤化化学品不同作用引起的两种主要职业和环境皮肤病”皮肤病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tokura Y.: "Augmentation of monocyte interleuki-8 production by psoralen/UVA-treated CD4+T cells"Exp. Dermatol.. 11. 564-572 (2002)
Tokura Y.:“补骨脂素/UVA 处理的 CD4 T 细胞增强单核细胞 interleuki-8 的产生”Exp。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Significance of kallikrein-5 in the formation of filaggrin monomer
-
批准号:24659525
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.41万
-
财政年份:2012
-
负责人:TOKURA Yoshiki
-
依托单位:
Control of itch by topical application of cholecystokinin and its use for novel therapy
-
批准号:22659208
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.02万
-
财政年份:2010
-
负责人:TOKURA Yoshiki
-
依托单位:
Establishment of monitoring system with AID-associated microRNA-155 for cutaneous T-cell lymphoma and its application for therapy
-
批准号:21390328
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.32万
-
财政年份:2009
-
负责人:TOKURA Yoshiki
-
依托单位:
Establishment of murine model of eosinophil-infiltrating drug photoallergy and elucidation of its immunological mechanism
-
批准号:18591267
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.4万
-
财政年份:2006
-
负责人:TOKURA Yoshiki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
-
批准号:82371224
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马柯
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
泛素结合酶UBE2S调控GPX4/SLC7A11影响肝癌细胞铁死亡的机制研究
-
批准号:32060159
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:莫之婧
-
依托单位:
m6A识别蛋白YTHDF2促白血病细胞生长的研究
-
批准号:32070793
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:赵昀
-
依托单位:
TCF7L2突变介导SMAD7信号轴抑制KRAS突变型结直肠癌转移及耐药的分子机制研究
-
批准号:32000555
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐亮
-
依托单位:
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
-
批准号:31900528
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2019
-
负责人:王真
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
-
批准号:81172109
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:柳凤亭
-
依托单位: